Transcription of New Zealand Data Sheet - Medsafe
{{id}} {{{paragraph}}}
1 tranexamic acid TABLETS tranexamic acid film-coated tablets 500 mg New Zealand Data Sheet 1 PRODUCT NAME tranexamic acid TABLETS 500 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 500 mg tranexamic acid . For the full list of excipients, see section 3 PHARMACEUTICAL FORM tranexamic acid Tablets are white, film-coated, oblong tablets, marked on one side with FW291 , with a break-line on the reverse. 4 CLINICAL PARTICULARS Therapeutic indications Haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis.
Tranexamic acid should not be given to patients with acquired disturbances of colour vision. If disturbances of colour vision arise during the course of treatment the drug should
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}